Featured in a Nikkei Biotech Interview

DLeader was featured in an interview by Nikkei Biotech ONLINE, a leading Japanese biotech industry publication. The interview introduced DLeader’s vision for KumiChem™, an AI platform designed to support researchers across the RNA drug discovery process, from target understanding and oligonucleotide design to candidate evaluation and prioritization.
As RNA therapeutics continue to expand beyond rare diseases into a broader range of therapeutic areas, DLeader is developing KumiChem™ to integrate fragmented scientific data, specialized models, and research workflows through Agentic AI. By connecting these elements within a unified platform, DLeader aims to make RNA drug discovery faster, more systematic, and more explainable.
The interview also covered DLeader’s collaborations with researchers, advisors, and industry partners across academia and biotechnology, as well as its plans to further expand partnerships with pharmaceutical companies, biotech companies, research institutions, and other partners in Japan and globally.